How Much Did Transcarent Raise?
Funding & Key Investors

Transcarent has secured substantial capital, with its total funding reaching $424M. The company recently announced a major strategic investment of $126M, underscoring its significant traction in the health and care platform sector. This latest financing round follows a series of strategic capital injections that have propelled the company's growth trajectory.

What is Transcarent?

Transcarent
SoftwareHealthcare SoftwareBusiness Services

Founded in 2018 and headquartered in San Francisco, California, Transcarent operates as a comprehensive health and care platform. It is designed to serve employees of self-insured employers and their families, connecting them with crucial information and expert advisors to support informed medical decision-making. The platform aims to simplify complex healthcare navigation and empower individuals to manage their health more effectively.

How much funding has Transcarent raised?

Transcarent has raised a total of $424M across 4 funding rounds:

2020

Series A

$40M

2021

Series B

$58M

2022

Series C

$200M

2024

Series D

$126M

Series A (2020): $40M with participation from 7wireVentures, Alta Partners, and General Catalyst

Series B (2021): $58M led by Kleiner Perkins, Merck Global Health Innovation Fund, General Catalyst, and 7wireVentures

Series C (2022): $200M supported by Kinnevik and The Human Capital Institute

Series D (2024): $126M featuring General Catalyst and 7wireVentures

Key Investors in Transcarent

General Catalyst

General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors and stages, backing entrepreneurs and management teams pursuing ambitious visions that reshape their respective industries.

7wireVentures

7wireVentures invests in early-stage digital health companies focused on creating informed and connected health consumers, aiming to revolutionize healthcare through innovative solutions.

Kleiner Perkins

Kleiner Perkins is a venture capital firm that invests in early and growth-stage technology and lifescience companies, backing founders across consumer, enterprise, healthcare, and climate/hard tech.

What's next for Transcarent?

The recent major enterprise-level funding indicates a strategic push for Transcarent to scale its operations and potentially expand its market reach. This significant capital infusion is likely to be directed towards enhancing its platform capabilities, broadening its service offerings, and forging new partnerships within the employer-sponsored healthcare ecosystem. The company's focus on empowering consumers through better information and advisory services positions it for continued growth in a rapidly evolving healthcare landscape.

See full Transcarent company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftwareManufacturingMedical Devices & EquipmentMobile App Development
Security SoftwareSoftware
Content & Collaboration SoftwareSoftware
Customer Engagement PlatformsSoftware

Frequently Asked Questions Regarding Transcarent Financial Insights

What are the most recent funding rounds that Transcarent has completed, and what were the funding rounds?
Transcarent has recently completed 3 funding rounds: Series D on May 2, 2024, Series C on Jan 11, 2022, Series B on Jun 10, 2021.
What is the total amount of funding Transcarent has raised to date?
Transcarent has raised a total of $424M in funding to date.
How many funding rounds has Transcarent completed?
Transcarent has completed 3 funding rounds.
How much funding did Transcarent raise in its most recent funding round?
Transcarent raised $126M in its most recent funding round.
Who are the lead investors in Transcarent's latest funding round?
The lead investor in Transcarent's latest funding round was General Catalyst. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Transcarent's history?
The largest funding round in Transcarent's history was $200M.
See more information about Transcarent